BACKGROUND: Adipocyte fatty acid binding protein (A-FABP) and adiponectin have been shown to play important roles in atherosclerosis. We investigated serum A-FABP, adiponectin and A-FABP/adiponectin ratio in patients with coronary artery disease (CAD). METHODS: A total of 340 subjects who underwent coronary angiography (CAG) were classified into CAD group (n=211) and non-CAD group (n=129) according to the CAG. Serum A-FABP and adiponectin concentrations were determined by enzyme-linked immunosorbent assays. RESULTS: CAD patients tend to have higher A-FABP concentrations than non-CAD subjects, the difference is significant only between female CAD patients and controls [22.8 (18.6-25.7) ng/ml vs 18.1 (15.6-21.8) ng/ml, P=0.008]. Serum A-FABP concentration was independently associated with Gensini scores in female subjects (P=0.018). CAD patients have significant higher serum A-FABP/adiponectin ratio [1.51 ± 0.05 vs 0.89 ± 0.03 ng/μg, P<0.01] than controls in both genders. CONCLUSIONS: Serum A-FABP is associated with CAD more closely in female than in male. The A-FABP/adiponectin ratio may be a more useful indicator for CAD than A-FABP or adiponectin alone. 2010 Elsevier B.V. All rights reserved.
BACKGROUND:Adipocyte fatty acid binding protein (A-FABP) and adiponectin have been shown to play important roles in atherosclerosis. We investigated serum A-FABP, adiponectin and A-FABP/adiponectin ratio in patients with coronary artery disease (CAD). METHODS: A total of 340 subjects who underwent coronary angiography (CAG) were classified into CAD group (n=211) and non-CAD group (n=129) according to the CAG. Serum A-FABP and adiponectin concentrations were determined by enzyme-linked immunosorbent assays. RESULTS: CAD patients tend to have higher A-FABP concentrations than non-CAD subjects, the difference is significant only between female CAD patients and controls [22.8 (18.6-25.7) ng/ml vs 18.1 (15.6-21.8) ng/ml, P=0.008]. Serum A-FABP concentration was independently associated with Gensini scores in female subjects (P=0.018). CAD patients have significant higher serum A-FABP/adiponectin ratio [1.51 ± 0.05 vs 0.89 ± 0.03 ng/μg, P<0.01] than controls in both genders. CONCLUSIONS: Serum A-FABP is associated with CAD more closely in female than in male. The A-FABP/adiponectin ratio may be a more useful indicator for CAD than A-FABP or adiponectin alone. 2010 Elsevier B.V. All rights reserved.
Authors: Clare B Kelly; Michelle B Hookham; Jeremy Y Yu; Samuel M Lockhart; Mei Du; Alicia J Jenkins; Alison Nankervis; Kristian F Hanssen; Tore Henriksen; Satish K Garg; Samar M Hammad; James A Scardo; Christopher E Aston; Christopher C Patterson; Timothy J Lyons Journal: Diabetologia Date: 2017-09-05 Impact factor: 10.122
Authors: Luc Djoussé; Traci M Bartz; Joachim H Ix; Jinesh Kochar; Jorge R Kizer; John S Gottdiener; Russell P Tracy; Dariush Mozaffarian; David S Siscovick; Kenneth J Mukamal; Susan J Zieman Journal: Eur J Heart Fail Date: 2012-12-06 Impact factor: 15.534
Authors: Luc Djoussé; Marlena Maziarz; Mary L Biggs; Joachim H Ix; Susan J Zieman; Jorge R Kizer; Rozenn N Lemaitre; Dariush Mozaffarian; Russell P Tracy; Kenneth J Mukamal; David S Siscovick; Nona Sotoodehnia Journal: Cardiol Res Pract Date: 2013-12-28 Impact factor: 1.866
Authors: Atlanta G I M Elie; Pia S Jensen; Katrine D Nissen; Ilvy M E Geraets; Aimin Xu; Erfei Song; Maria L Hansen; Akhmadjon Irmukhamedov; Lars M Rasmussen; Yu Wang; Jo G R De Mey Journal: PLoS One Date: 2016-05-03 Impact factor: 3.240